AnGes Inc
F:AJW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AnGes Inc
F:AJW
|
JP |
|
Aoyama Trading Co Ltd
OTC:AYAMF
|
JP |
|
B
|
Boiron SA
XMUN:BON
|
FR |
|
GMV Minerals Inc
F:G3MN
|
CA |
|
H
|
Harmonic Inc
LSE:0J38
|
US |
|
C
|
Comet Ridge Ltd
XBER:DD3
|
AU |
|
Kewpie Corp
OTC:KWPCF
|
JP |
|
S
|
Sound Energy PLC
F:88S1
|
UK |
|
I
|
IDH Development SA
F:7E2
|
PL |
|
S
|
Sumitomo Bakelite Co Ltd
XMUN:SZ8
|
JP |
|
N
|
Nevro Corp
SWB:1N7
|
US |
|
China Evergrande Group
F:EV1
|
CN |
|
Katitas Co Ltd
OTC:KTITF
|
JP |
|
M
|
Manolete Partners PLC
OTC:MANOF
|
UK |
|
ULS Group Inc
OTC:ULPRF
|
JP |
|
Corbion NV
AEX:CRBN
|
NL |
|
H
|
Harmonic Inc
SWB:HMC
|
US |
|
D
|
Daio Paper Corp
XBER:DPR
|
JP |
|
Bank7 Corp
F:J0N
|
US |
|
G
|
G3 Exploration Ltd
F:G3J
|
CN |
|
M
|
MPC Muenchmeyer Petersen Capital AG
SWB:MPCK
|
DE |
|
Nextleaf Solutions Ltd
F:L0MA
|
CA |
|
Jins Holdings Inc
F:5F3
|
JP |
|
National Express Group PLC
LSE:NEX
|
UK |
Bankruptcy Probability
AnGes Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
AnGes Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JP |
|
AnGes Inc
TSE:4563
|
15.5B JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
182.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
AnGes Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, AnGes Inc has total debt of 650.1m JPY. This includes both short-term (0 JPY) and long-term (650.1m JPY) debt.
You can find a full breakdown on its Balance Sheet.
